Université de Paris-Saclay, Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Département Médicaments et Technologies pour la Santé, Service d'Ingénierie Moléculaire pour la Santé (SIMoS), Gif-sur-Yvette, France.
Front Immunol. 2024 Mar 6;15:1345195. doi: 10.3389/fimmu.2024.1345195. eCollection 2024.
Non-mutated FVIII-specific CD4 T cell epitopes have been recently found to contribute to the development of inhibitors in patients with hemophilia A (HA), while auto-reactive CD4 T cells specific to FVIII circulate in the blood of healthy individuals at a frequency close to the foreign protein ovalbumin. Thus, although FVIII is a self-protein, the central tolerance raised against FVIII appears to be low. In this study, we conducted a comprehensive analysis of the FVIII CD4 T cell repertoire in 29 healthy donors. Sequencing of the CDR3β TCR region from isolated FVIII-specific CD4 T cells revealed a limited usage and pairing of TRBV and TRBJ genes as well as a mostly hydrophobic composition of the CDR3β region according to their auto-reactivity. The FVIII repertoire is dominated by a few clonotypes, with only 13 clonotypes accounting for half of the FVIII response. Through a large-scale epitope mapping of the full-length FVIII sequence, we identified 18 immunodominant epitopes located in the A1, A3, C1, and C2 domains and covering half of the T cell response. These epitopes exhibited a broad specificity for HLA-DR or DP molecules or both. T cell priming with this reduced set of peptides revealed that highly expanded clonotypes specific to these epitopes were responsible individually for up to 32% of the total FVIII repertoire. These FVIII T cell epitopes and clonotypes were shared among HLA-unrelated donors tested and previously reported HA patients. Our study highlights the role of the auto-reactive T cell response against FVIII in HA and its similarity to the response observed in healthy individuals. Thus, it provides valuable insights for the development of new tolerance induction and deimmunization strategies.
最近发现,非突变的 FVIII 特异性 CD4 T 细胞表位有助于血友病 A (HA) 患者产生抑制剂,而针对 FVIII 的自身反应性 CD4 T 细胞在健康个体的血液中循环,其频率接近外源性蛋白卵清蛋白。因此,尽管 FVIII 是一种自身蛋白,但针对 FVIII 的中枢耐受似乎较低。在这项研究中,我们对 29 名健康供体的 FVIII CD4 T 细胞库进行了全面分析。从分离的 FVIII 特异性 CD4 T 细胞中 CDR3β TCR 区域的测序显示,TRBV 和 TRBJ 基因的使用和配对有限,以及 CDR3β 区域的大部分为疏水性,这与其自身反应性有关。FVIII 库主要由少数克隆型组成,只有 13 个克隆型占 FVIII 反应的一半。通过对全长 FVIII 序列的大规模表位作图,我们鉴定出 18 个免疫显性表位,位于 A1、A3、C1 和 C2 结构域,覆盖了 T 细胞反应的一半。这些表位对 HLA-DR 或 DP 分子或两者均具有广泛的特异性。用这组减少的肽进行 T 细胞启动显示,针对这些表位的高度扩增的克隆型分别负责高达 32%的总 FVIII 库。这些 FVIII T 细胞表位和克隆型在测试的 HLA 无关供体和先前报道的 HA 患者中共享。我们的研究强调了针对 FVIII 的自身反应性 T 细胞反应在 HA 中的作用及其与健康个体中观察到的反应的相似性。因此,它为新的诱导耐受和去免疫化策略的发展提供了有价值的见解。